<DOC>
	<DOCNO>NCT01569724</DOCNO>
	<brief_summary>Bexarotene RXR-selective retinoid , license treatment cutaneous T cell lymphoma . The frequent adverse effect hypertriglyceridemia mechanism well know . The purpose study research carbohydrate metabolism disorder associate bexarotene-induced hypertriglyceridemia .</brief_summary>
	<brief_title>Carbohydrate Metabolism Disorder Frequency Hypertriglyceridemia Induced Bexarotene Cutaneous T Cell Lymphoma</brief_title>
	<detailed_description>Primary cutaneous lymphomas second group extra nodal lymphomas gastrointestinal lymphoma . Bexarotene license treatment epidermotropic cutaneous T cell lymphoma .The common side effect bexarotene hypertriglyceridemia ( 82 % ) associate hypercholesterolemia ( 30 40 % ) . Central hypothyroidism also present 40-80 % case . These adverse effect dose-dependent . The management hyperlipidemia induce bexarotene difficult . The mechanism lipid disorder induce bexarotene well know . Associated carbohydrate metabolism disorder could present play role bexarotene-induced hyperlipidemia . The main objective estimate frequency carbohydrate disorder patient hypertriglyceridemia ( TG &gt; 1.5 g / L ) induce bexarotene treatment cutaneous T cell lymphoma , previously free diabetes , thyroid dysfunction dyslipidemia .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , T-Cell</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Hypertriglyceridemia</mesh_term>
	<mesh_term>Lymphoma , T-Cell , Cutaneous</mesh_term>
	<mesh_term>Bexarotene</mesh_term>
	<criteria>Patient age 18 year Diagnosis epidermotropic CTCL confirm histological examination consideration give treatment bexarotene due advance stage lymphoma ( stage IIBIV ) early stage resistance previous treatment . TSH , FT3 FT4 within normal limit AST ALT ≤ 2 * upper limit normal Creatinine clearance ≥ 30 mL / min Agreement write information inform participate study Patient accept constraint study Membership social security system . Pregnant lactate woman Women childbearing potential without effective contraception Insufficient thyroid hyperthyroidism Diabetes know detected Hyperlipidemia know detect Hepatic insufficiency Difficulties understand Persons cover plan legal protection ( protection justice , guardianship , curator ) unable issue consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>hypertriglyceridemia</keyword>
	<keyword>bexarotene</keyword>
</DOC>